• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸苷激酶 1 沉默通过 E2F1-TK1-P21 轴抑制胰腺癌细胞的增殖活性。

Thymidine kinase 1 silencing retards proliferative activity of pancreatic cancer cell via E2F1-TK1-P21 axis.

机构信息

Pancreas Center, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China.

Pancreas Institute, Nanjing Medical University, Nanjing, Jiangsu Province, China.

出版信息

Cell Prolif. 2018 Jun;51(3):e12428. doi: 10.1111/cpr.12428. Epub 2017 Dec 20.

DOI:10.1111/cpr.12428
PMID:29266545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6528927/
Abstract

OBJECTIVES

Thymidine kinase 1 (TK1) is one of the salvage enzymes engaged in the synthesis of DNA. Although a pro-carcinogenetic role of TK1 has been reported in various types of cancers, its role in pancreatic ductal adenocarcinoma (PDAC) is still unknown. The study is aimed to elaborate the function of TK1 in PDAC and the potential mechanisms in the following study.

MATERIALS AND METHODS

TK1 expression was analysed by immunohistochemistry, real-time PCR and Western blot, and its relationship with clinicopathological characteristics of PDAC patients was further investigated. To verify the function of TK1 and potential mechanism, TK1 siRNA was used to transfect PDAC cells and performed a series of assays in cell and animal models.

RESULTS

The level of TK1 expression was higher in cancerous tissues compared with matched adjacent tissues. TK1 overexpression was associated with progression of PDAC and poor prognosis. Knockdown of TK1 could suppress cell proliferation via inducing S phase arrest mediated by upregulation of P21. Further mechanism investigation suggested that transcription factor E2F-1 could directly regulate the TK1 and promote tumour proliferation.

CONCLUSIONS

The results suggested that TK1 might be involved in the development and progression of PDAC by regulating cell proliferation and show that TK1 may work as a promising therapeutic target in patients with PDAC.

摘要

目的

胸苷激酶 1(TK1)是参与 DNA 合成的补救酶之一。虽然在各种类型的癌症中已经报道了 TK1 的致癌前作用,但它在胰腺导管腺癌(PDAC)中的作用仍不清楚。本研究旨在阐述 TK1 在 PDAC 中的功能及其在以下研究中的潜在机制。

材料和方法

通过免疫组织化学、实时 PCR 和 Western blot 分析 TK1 的表达,并进一步研究其与 PDAC 患者临床病理特征的关系。为了验证 TK1 的功能和潜在机制,使用 TK1 siRNA 转染 PDAC 细胞,并在细胞和动物模型中进行了一系列实验。

结果

与配对的相邻组织相比,癌组织中 TK1 的表达水平更高。TK1 的过表达与 PDAC 的进展和预后不良相关。TK1 的敲低可通过上调 P21 诱导 S 期阻滞来抑制细胞增殖。进一步的机制研究表明,转录因子 E2F-1 可以直接调节 TK1 并促进肿瘤增殖。

结论

这些结果表明,TK1 可能通过调节细胞增殖参与 PDAC 的发生和发展,并表明 TK1 可能成为 PDAC 患者有前途的治疗靶点。

相似文献

1
Thymidine kinase 1 silencing retards proliferative activity of pancreatic cancer cell via E2F1-TK1-P21 axis.胸苷激酶 1 沉默通过 E2F1-TK1-P21 轴抑制胰腺癌细胞的增殖活性。
Cell Prolif. 2018 Jun;51(3):e12428. doi: 10.1111/cpr.12428. Epub 2017 Dec 20.
2
Long noncoding RNA Linc00337 functions as an E2F1 co-activator and promotes cell proliferation in pancreatic ductal adenocarcinoma.长链非编码 RNA Linc00337 作为 E2F1 共激活因子发挥作用,促进胰腺导管腺癌中的细胞增殖。
J Exp Clin Cancer Res. 2020 Oct 14;39(1):216. doi: 10.1186/s13046-020-01725-5.
3
The long noncoding RNA H19 promotes cell proliferation via E2F-1 in pancreatic ductal adenocarcinoma.长链非编码RNA H19通过E2F-1促进胰腺导管腺癌的细胞增殖。
Cancer Biol Ther. 2016 Oct 2;17(10):1051-1061. doi: 10.1080/15384047.2016.1219814. Epub 2016 Aug 29.
4
Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.FOXO3a 的敲低通过 SPRY2 激活 β-catenin/TCF4 通路诱导胰腺导管腺癌的上皮-间充质转化并促进转移。
J Exp Clin Cancer Res. 2019 Jan 28;38(1):38. doi: 10.1186/s13046-019-1046-x.
5
RACK1 overexpression associates with pancreatic ductal adenocarcinoma growth and poor prognosis.RACK1过表达与胰腺导管腺癌的生长及不良预后相关。
Exp Mol Pathol. 2016 Oct;101(2):176-186. doi: 10.1016/j.yexmp.2016.08.001. Epub 2016 Aug 3.
6
High HDAC9 is associated with poor prognosis and promotes malignant progression in pancreatic ductal adenocarcinoma.高表达的组蛋白去乙酰化酶 9 与不良预后相关,并促进胰腺导管腺癌的恶性进展。
Mol Med Rep. 2020 Feb;21(2):822-832. doi: 10.3892/mmr.2019.10869. Epub 2019 Dec 6.
7
YY1 suppresses proliferation and migration of pancreatic ductal adenocarcinoma by regulating the CDKN3/MdM2/P53/P21 signaling pathway.YY1 通过调控 CDKN3/MdM2/P53/P21 信号通路抑制胰腺导管腺癌的增殖和迁移。
Int J Cancer. 2018 Apr 1;142(7):1392-1404. doi: 10.1002/ijc.31173. Epub 2017 Dec 4.
8
The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer.长链非编码RNA HOTTIP通过调控HOXA13促进胰腺癌进展及吉西他滨耐药。
J Transl Med. 2015 Mar 12;13:84. doi: 10.1186/s12967-015-0442-z.
9
Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b.上调的环状 RNA circ_0007534 表明胰腺导管腺癌预后不良,并通过海绵吸附 miR-625 和 miR-892b 来调节细胞增殖、凋亡和侵袭。
J Cell Biochem. 2019 Mar;120(3):3780-3789. doi: 10.1002/jcb.27658. Epub 2018 Nov 1.
10
An increased expression of long non-coding RNA PANDAR promotes cell proliferation and inhibits cell apoptosis in pancreatic ductal adenocarcinoma.长链非编码 RNA PANDAR 的表达增加促进胰腺导管腺癌细胞增殖并抑制细胞凋亡。
Biomed Pharmacother. 2017 Nov;95:685-691. doi: 10.1016/j.biopha.2017.08.124. Epub 2017 Sep 7.

引用本文的文献

1
Proteomics analysis and immune profiling reveal regulators of PD-L1 in oesophageal squamous cell carcinoma.蛋白质组学分析和免疫图谱揭示食管鳞状细胞癌中PD-L1的调节因子。
Br J Cancer. 2025 Jun 10. doi: 10.1038/s41416-025-03068-4.
2
Dual-directional epi-genotoxicity assay for assessing chemically induced epigenetic effects utilizing the housekeeping TK gene.利用看家基因TK进行化学诱导表观遗传效应评估的双向表观遗传毒性试验。
Sci Rep. 2025 Mar 5;15(1):7780. doi: 10.1038/s41598-025-92121-6.
3
Targeted Inhibition of p21 Promotes the Growth of Breast Cancer Cells and Impairs the Tumor-Killing Effect of the Vaccinia Virus.对p21的靶向抑制促进乳腺癌细胞生长并削弱痘苗病毒的肿瘤杀伤作用。
J Breast Cancer. 2024 Oct;27(5):293-304. doi: 10.4048/jbc.2024.0063. Epub 2024 Sep 2.
4
Pan-cancer analysis reveals that TK1 promotes tumor progression by mediating cell proliferation and Th2 cell polarization.泛癌分析表明,胸苷激酶1(TK1)通过介导细胞增殖和辅助性T细胞2(Th2)极化促进肿瘤进展。
Cancer Cell Int. 2024 Sep 29;24(1):329. doi: 10.1186/s12935-024-03515-x.
5
E2F transcription factors promote tumorigenicity in pancreatic ductal adenocarcinoma.E2F 转录因子促进胰腺导管腺癌的肿瘤发生。
Cancer Med. 2024 May;13(9):e7187. doi: 10.1002/cam4.7187.
6
TK1 expression influences pathogenicity by cell cycle progression, cellular migration, and cellular survival in HCC 1806 breast cancer cells.TK1 表达通过细胞周期进程、细胞迁移和细胞存活影响 HCC1806 乳腺癌细胞的致病性。
PLoS One. 2023 Nov 30;18(11):e0293128. doi: 10.1371/journal.pone.0293128. eCollection 2023.
7
Multi-Omics Integration Analysis of TK1 in Glioma: A Potential Biomarker for Predictive, Preventive, and Personalized Medical Approaches.胶质瘤中TK1的多组学整合分析:一种用于预测、预防和个性化医疗方法的潜在生物标志物。
Brain Sci. 2023 Jan 30;13(2):230. doi: 10.3390/brainsci13020230.
8
mC-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6/TK1 mRNAs splicing and stabilization.ALYREF 与 NSUN2 之间的 mC 依赖性交叉调控通过促进 RABL6/TK1 mRNA 的剪接和稳定来促进尿路上皮膀胱癌的恶性进展。
Cell Death Dis. 2023 Feb 18;14(2):139. doi: 10.1038/s41419-023-05661-y.
9
Methylation status of TK1 correlated with immune infiltrates in prostate cancer.胸苷激酶1(TK1)的甲基化状态与前列腺癌中的免疫浸润相关。
Front Genet. 2022 Aug 11;13:899384. doi: 10.3389/fgene.2022.899384. eCollection 2022.
10
A comprehensive analysis of ncRNA-mediated interactions reveals potential prognostic biomarkers in prostate adenocarcinoma.对非编码RNA介导的相互作用进行的全面分析揭示了前列腺腺癌中潜在的预后生物标志物。
Comput Struct Biotechnol J. 2022 Jul 14;20:3839-3850. doi: 10.1016/j.csbj.2022.07.020. eCollection 2022.

本文引用的文献

1
The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells.在前列腺癌细胞中,雄激素信号传导可迅速抑制 prohibitin 与 E2F1 的抑制性相互作用。
Oncogenesis. 2017 May 15;6(5):e333. doi: 10.1038/oncsis.2017.32.
2
PEG10 overexpression induced by E2F-1 promotes cell proliferation, migration, and invasion in pancreatic cancer.E2F-1诱导的PEG10过表达促进胰腺癌细胞的增殖、迁移和侵袭。
J Exp Clin Cancer Res. 2017 Feb 13;36(1):30. doi: 10.1186/s13046-017-0500-x.
3
Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression.鉴定脆性组氨酸三联体基因作为胸苷激酶 1 表达的转录后效应子。
Biochim Biophys Acta Gene Regul Mech. 2017 Mar;1860(3):374-382. doi: 10.1016/j.bbagrm.2017.01.005. Epub 2017 Jan 14.
4
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
5
Thymidine kinase 1 is a better prognostic marker than Ki-67 for pT1 adenocarcinoma of the lung.对于肺pT1腺癌,胸苷激酶1是比Ki-67更好的预后标志物。
Int J Clin Exp Med. 2014 Aug 15;7(8):2120-8. eCollection 2014.
6
Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism.阴阳-1通过在MUC4/ErbB2/p38/MEF2C依赖机制中下调基质金属蛋白酶10来抑制胰腺导管腺癌的侵袭和转移。
Mol Cancer. 2014 May 29;13:130. doi: 10.1186/1476-4598-13-130.
7
Understanding metastasis in pancreatic cancer: a call for new clinical approaches.理解胰腺癌转移:对新临床方法的呼吁。
Cell. 2012 Jan 20;148(1-2):21-3. doi: 10.1016/j.cell.2011.12.021.
8
Thymidine kinase and cancer monitoring.胸苷激酶与癌症监测。
Cancer Lett. 2012 Mar;316(1):6-10. doi: 10.1016/j.canlet.2011.10.025. Epub 2011 Nov 6.
9
XPA-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrence.XPA-210:一种新的增殖标志物,可确定局部晚期前列腺癌,并预测生化复发。
World J Urol. 2012 Aug;30(4):547-52. doi: 10.1007/s00345-011-0768-y. Epub 2011 Oct 4.
10
Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.在肾细胞癌(RCC)和嗜酸细胞瘤中暴露的增殖抗原 210(XPA-210):临床应用和生物学意义。
BJU Int. 2012 Feb;109(4):634-8. doi: 10.1111/j.1464-410X.2011.10392.x. Epub 2011 Jun 28.